These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37017703)
1. Diffusion magnetic resonance imaging for kidney cyst volume quantification and non-cystic tissue characterisation in ADPKD. Caroli A; Villa G; Brambilla P; Trillini M; Sharma K; Sironi S; Remuzzi G; Perico N; Remuzzi A Eur Radiol; 2023 Sep; 33(9):6009-6019. PubMed ID: 37017703 [TBL] [Abstract][Full Text] [Related]
2. Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study. Suwabe T; Ubara Y; Ueno T; Hayami N; Hoshino J; Imafuku A; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Saitoh S; Okuda I; Takaichi K BMC Nephrol; 2016 Nov; 17(1):170. PubMed ID: 27829402 [TBL] [Abstract][Full Text] [Related]
3. Novel three-dimensional imaging volumetry in autosomal dominant polycystic kidney disease: comparison with 2D volumetry. Shin D; Lee KB; Hyun YY; Lee YR; Hwang YH; Park HC; Ahn C Clin Nephrol; 2014 Aug; 82(2):98-106. PubMed ID: 25029513 [TBL] [Abstract][Full Text] [Related]
4. Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study. Bjornstad P; Richard G; Choi YJ; Nowak KL; Steele C; Chonchol MB; Nadeau KJ; Vigers T; Pyle L; Tommerdahl K; van Raalte DH; Hilkin A; Driscoll L; Birznieks C; Hopp K; Wang W; Edelstein C; Nelson RG; Gregory AV; Kline TL; Blondin D; Gitomer B Am J Kidney Dis; 2024 Sep; 84(3):286-297.e1. PubMed ID: 38621633 [TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Kidney Parenchyma-T2 as a Novel Imaging Biomarker for Autosomal Dominant Polycystic Kidney Disease. Siedek F; Grundmann F; Weiss K; Pinto Dos Santos D; Arjune S; Haneder S; Persigehl T; Müller RU; Baessler B Invest Radiol; 2020 Apr; 55(4):217-225. PubMed ID: 31876626 [TBL] [Abstract][Full Text] [Related]
6. Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model. Yu Y; Shumway KL; Matheson JS; Edwards ME; Kline TL; Lyons LA BMC Nephrol; 2019 Jul; 20(1):259. PubMed ID: 31299928 [TBL] [Abstract][Full Text] [Related]
7. nnUNet for Automatic Kidney and Cyst Segmentation in Autosomal Dominant Polycystic Kidney Disease. Krishnan C; Schmidt E; Onuoha E; Mrug M; Cardenas CE; Kim H Curr Med Imaging; 2024; 20():1-9. PubMed ID: 38389364 [TBL] [Abstract][Full Text] [Related]
8. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease. Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110 [TBL] [Abstract][Full Text] [Related]
9. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease. Coban M; Inci A Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395 [TBL] [Abstract][Full Text] [Related]
10. Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease. Farooq Z; Behzadi AH; Blumenfeld JD; Zhao Y; Prince MR Clin Imaging; 2018; 47():41-46. PubMed ID: 28846875 [TBL] [Abstract][Full Text] [Related]
11. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP; Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554 [TBL] [Abstract][Full Text] [Related]
13. Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease. Bae KT; Tao C; Feldman R; Yu ASL; Torres VE; Perrone RD; Chapman AB; Brosnahan G; Steinman TI; Braun WE; Mrug M; Bennett WM; Harris PC; Srivastava A; Landsittel DP; Abebe KZ; Clin J Am Soc Nephrol; 2022 Mar; 17(3):374-384. PubMed ID: 35217526 [TBL] [Abstract][Full Text] [Related]
14. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease. Bae KT; Zhou W; Shen C; Landsittel DP; Wu Z; Tao C; Chapman AB; Torres VE; Yu ASL; Mrug M; Bennett WM; Harris PC; Clin J Am Soc Nephrol; 2019 Jun; 14(6):823-833. PubMed ID: 31088850 [TBL] [Abstract][Full Text] [Related]
15. A Deep Learning Approach for Automated Segmentation of Kidneys and Exophytic Cysts in Individuals with Autosomal Dominant Polycystic Kidney Disease. Kim Y; Tao C; Kim H; Oh GY; Ko J; Bae KT J Am Soc Nephrol; 2022 Aug; 33(8):1581-1589. PubMed ID: 35768178 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment. Turco D; Busutti M; Mignani R; Magistroni R; Corsi C Am J Nephrol; 2017; 45(5):373-379. PubMed ID: 28315882 [TBL] [Abstract][Full Text] [Related]
19. Abdominal Imaging in ADPKD: Beyond Total Kidney Volume. Caroli A; Kline TL J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568535 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP; Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]